CTOR
Citius Oncology Inc.

1,375
Mkt Cap
$107.7M
Volume
217,751.00
52W High
$6.19
52W Low
$0.5506
PE Ratio
-3.61
CTOR Fundamentals
Price
$1.22
Prev Close
$1.18
Open
$1.20
50D MA
$1.12
Beta
-2.45
Avg. Volume
247,051.60
EPS (Annual)
-$0.338
P/B
2.27
$148.61
Loading...
Loading...
News
all
press releases
Citius Oncology (NASDAQ:CTOR) Posts Earnings Results, Hits Estimates
Citius Oncology (NASDAQ:CTOR - Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.06) earnings per share for the quarter, hitting the consensus estimate of...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Citius Oncology Q1 Earnings Summary & Key Takeaways
read more...
Benzinga·2d ago
News Placeholder
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of...
PR Newswire·2d ago
News Placeholder
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR PR Newswire...
PR Newswire·2d ago
News Placeholder
Citius Oncology Expands International Distribution of LYMPHIR to European Union Through Exclusive Agreement with Uniphar
Citius Oncology Expands International Distribution of LYMPHIR to European Union Through Exclusive Agreement with Uniphar Citius Oncology Expands International Distribution of LYMPHIR to European...
PR Newswire·4d ago
News Placeholder
Citius Oncology, Inc. (NASDAQ:CTOR) Short Interest Up 22.3% in January
Citius Oncology, Inc. (NASDAQ:CTOR - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 15th, there was short interest totaling...
MarketBeat·11d ago
News Placeholder
Short Interest in Citius Oncology, Inc. (NASDAQ:CTOR) Expands By 51.2%
Citius Oncology, Inc. (NASDAQ:CTOR - Get Free Report) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totaling 983,877 shares, a...
MarketBeat·29d ago
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...
PR Newswire·1mo ago
News Placeholder
Citius Oncology, Inc. (NASDAQ:CTOR) Short Interest Update
Citius Oncology, Inc. (NASDAQ:CTOR - Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 650,544 shares, an...
MarketBeat·2mo ago
News Placeholder
Citius Oncology, Inc. Full Year Loss Increases
(RTTNews) - Citius Oncology, Inc. (CTOR) reported Loss for its full year of -$24.76 million...
Nasdaq News: Markets·2mo ago
<
1
2
...
>

Latest CTOR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.